期刊文献+

原发性中枢神经系统淋巴瘤20例的CT与MRI诊断 被引量:2

Diagnosis of primary central nervous system lymphoma with using CT and MRI
全文增补中
导出
摘要 目的探讨原发性中枢神经系统淋巴瘤(PCNSL)患者的 CT 与 MRI 表现特点,提高对该疾病的认识和诊断水平。方法回顾性分析20例免疫功能正常,经病理证实为 PCNSL 患者的 CT 与MRI 资料,所有患者均行 MRI 平扫及增强扫描,其中2例同时行 CT 直接增强扫描,6例行 CT 平扫,1例行 CT 平扫并增强。结果病灶单发14例,多发6例,共38个病灶,大部分位于脑表面或近中线部位(血管入脑的部位);密度与信号特点类似脑膜瘤;增强后明显强化,边缘有"毛刺征"(36/38)。结论颅内原发淋巴瘤影像表现虽然多种多样,但其影像仍具有一定的特点,特别是 PCNSL 的发病部位、信号特征和增强后边缘的"短毛刺"较有特征。 Objective To evaluate the CT and MRI characteristics of Primary Central Nervous System Lymphoma(PCNSL)in immunocompetent patients,and enhance its diagnosis level.Methods CT and MRI data of 20 patients with PCNSL confirmed by histo-pathology were analyzed retrospectively.MRI scans were performed with and without Gadolinium contrast.Two of them had contrast-enhanced CT scan;six had CT scan without contrast administration;1 had CT scan with both non-contrast and contrast enhancement.Re- suits Totally,38 lesions were found in all patients:14 lesions of them were single and 24 lesions were found in 6 patients.Generally,the lesions were located in the surface and/or midline of the brain.The signal features and density were similar to meningioma,and strongly enhancing after contrast administration.Thirty-six of the 38 lesions had spicular sign peripheral to the lesion.Conclusion Although the manifestations of the PCNSL are variety,there are still many characteristics in the medical imaging,especially in the locations,the signal features,and spicular sign in the edge of the lesions after contrast material injection.
出处 《肿瘤研究与临床》 CAS 2007年第9期597-599,共3页 Cancer Research and Clinic
关键词 中枢神经系统肿瘤 淋巴瘤 体层摄影术 螺旋计算机 磁共振成像 Central nervous system neoplasms Lymphoma Tomography,spiral computer Magnetic resonance imaging
  • 相关文献

参考文献6

二级参考文献17

  • 1石群立,张泰和,钱源澄,严小娟.原发性中枢神经系统淋巴瘤bcl-2蛋白的表达[J].中华病理学杂志,1996,25(3):171-171. 被引量:41
  • 2杨小平,张念察,李坤成,李慎茂,高勇安.中枢神经系统原发性淋巴瘤—影像学与病理对照分析[J].临床放射学杂志,1997,16(1):12-14. 被引量:13
  • 3Guo AC, Cummings TJ, Dash RC, et al. Lymphomas and high-grade astrocytomas: Comparison of water diffusibility and histologic characteristics[J] Radiology, 2002,224 (1): 177~ 183. 被引量:1
  • 4Koeller KK, Smirniotopoulos JG , Jones RV. Primary central nervous system lymphoma: radiologic-pathologic correlation [J].Radio-Graphics, 1997, 17:1497~1526. 被引量:1
  • 5Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol,1995,147:9-19. 被引量:1
  • 6Bakshi R, Mazziotta JC, Mischel PS, et al. Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord, 1999 ,10: 152-157. 被引量:1
  • 7Jenkins CN, Colquhoun IR. Characterization of primary intracranial lymphoma by computed tomography: an analysis of 36 cases and a review of the literature with particular reference to calcification haemorrhage and cyst formation. Clin Radiol, 1998, 53: 428-434. 被引量:1
  • 8Hartmann M, Sartor K. Primary malignant lymphoma of the brain. Radiologe, 1997,37: 42-50. 被引量:1
  • 9Sugahara T, Korogi Y, Shigematsu Y, et al. Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. Top Magn Reson Imaging, 1999, 10: 114-124. 被引量:1
  • 10Sugahara T, Korogi Y, Shigematsu Y, et al. Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr, 1999, 23: 232-237. 被引量:1

共引文献234

同被引文献22

  • 1张登晓.中枢神经系统非霍奇金淋巴瘤2例[J].白血病.淋巴瘤,2005,14(6):384-384. 被引量:1
  • 2HerrlingcrU, Schabet M, Clemens M,et al. Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.Aeta Neurol Stand, 1998,97 : 257. 被引量:1
  • 3Coreoran C,Rebe K,van der Plas H,et al. The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons. J Clin Virol, 2008,42 : 433-436. 被引量:1
  • 4Hayabuchi N, Shibamoto Y, Onizuka Y. Primary central nervous system lymphoma in Japan:a nationwide survey. Int J Radiat Oncol Biol Phys, 1999, 44: 265-272. 被引量:1
  • 5Reni M, Ferri A JM, Garancini MP,et al. Therapeutic managementof a primary central nervous system lymphoma in immunocompetent patients:results of a critical review of the literature. Annal Oneol, 1997,8 : 227. 被引量:1
  • 6Seiferheld W,School SC. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma:Radiation Therapy Oncology Group Study 93-10. J Clin Oncol, 2002,20:4643-4648. 被引量:1
  • 7Chihara D, Oki Y, Matsuo K, et al. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: analyses with competing risk regression model. Leuk Lymphoma, 2011,52: 2270-2275. 被引量:1
  • 8Bernstein SH, Unger JM, Leblanc M, et al. Natural history of CNS relapse in patients with aggressive non-Hodgkin lymphoma: a 20-year follow up analysis of SWOG 8516-The Southwest Oncology Group. J Clin Oncol, 2009, 27:114-119. 被引量:1
  • 9Villa D, Connors JM, Shenkier TN, et al. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol, 2010, 21: 1046-1052. 被引量:1
  • 10Papageorgiou SG, Diamantopoulos P, Levidou G, et al. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without rituximab. Hematol Oncol, 2012 May 18. doi: 10.1002/hon.2012. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部